nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—Topoisomerase Inhibitors—Mitoxantrone—multiple sclerosis	0.724	1	CiPCiCtD
Idarubicin—TOP2A—Mitoxantrone—multiple sclerosis	0.0923	0.457	CbGbCtD
Idarubicin—ABCC1—Mitoxantrone—multiple sclerosis	0.0511	0.253	CbGbCtD
Idarubicin—CYP2D6—Fingolimod—multiple sclerosis	0.0247	0.122	CbGbCtD
Idarubicin—ABCC1—Methotrexate—multiple sclerosis	0.0213	0.105	CbGbCtD
Idarubicin—CYP2C9—Dexamethasone—multiple sclerosis	0.00659	0.0326	CbGbCtD
Idarubicin—CYP2D6—Dexamethasone—multiple sclerosis	0.00603	0.0298	CbGbCtD
Idarubicin—TOP2A—Floxuridine—Cladribine—multiple sclerosis	0.000478	0.378	CbGdCrCtD
Idarubicin—TOP2A—Clofarabine—Cladribine—multiple sclerosis	0.000334	0.265	CbGdCrCtD
Idarubicin—TOP2A—Azacitidine—Cladribine—multiple sclerosis	0.000204	0.161	CbGdCrCtD
Idarubicin—Thrombophlebitis—Betamethasone—multiple sclerosis	0.000159	0.00221	CcSEcCtD
Idarubicin—Extravasation—Methotrexate—multiple sclerosis	0.000158	0.0022	CcSEcCtD
Idarubicin—Chest pain—Cladribine—multiple sclerosis	0.000157	0.00218	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.000156	0.00216	CcSEcCtD
Idarubicin—Immune system disorder—Azathioprine—multiple sclerosis	0.000155	0.00216	CcSEcCtD
Idarubicin—Chills—Azathioprine—multiple sclerosis	0.000154	0.00214	CcSEcCtD
Idarubicin—Arrhythmia—Azathioprine—multiple sclerosis	0.000154	0.00213	CcSEcCtD
Idarubicin—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.000153	0.00212	CcSEcCtD
Idarubicin—Alopecia—Azathioprine—multiple sclerosis	0.000152	0.00211	CcSEcCtD
Idarubicin—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.000152	0.00211	CcSEcCtD
Idarubicin—Cardiac failure congestive—Dexamethasone—multiple sclerosis	0.000152	0.00211	CcSEcCtD
Idarubicin—Cardiac failure congestive—Betamethasone—multiple sclerosis	0.000152	0.00211	CcSEcCtD
Idarubicin—Stomatitis—Mitoxantrone—multiple sclerosis	0.000151	0.0021	CcSEcCtD
Idarubicin—Oesophagitis—Prednisone—multiple sclerosis	0.000151	0.00209	CcSEcCtD
Idarubicin—Infection—Cladribine—multiple sclerosis	0.000149	0.00207	CcSEcCtD
Idarubicin—Hyperuricaemia—Methotrexate—multiple sclerosis	0.000149	0.00206	CcSEcCtD
Idarubicin—Thrombocytopenia—Cladribine—multiple sclerosis	0.000147	0.00204	CcSEcCtD
Idarubicin—Skin disorder—Cladribine—multiple sclerosis	0.000146	0.00203	CcSEcCtD
Idarubicin—Ulcer—Methotrexate—multiple sclerosis	0.000146	0.00202	CcSEcCtD
Idarubicin—Anorexia—Cladribine—multiple sclerosis	0.000143	0.00199	CcSEcCtD
Idarubicin—Sepsis—Prednisone—multiple sclerosis	0.000143	0.00199	CcSEcCtD
Idarubicin—Blood uric acid increased—Methotrexate—multiple sclerosis	0.000141	0.00195	CcSEcCtD
Idarubicin—Haemoglobin—Mitoxantrone—multiple sclerosis	0.00014	0.00194	CcSEcCtD
Idarubicin—Haemorrhage—Mitoxantrone—multiple sclerosis	0.000139	0.00193	CcSEcCtD
Idarubicin—Thrombophlebitis—Prednisone—multiple sclerosis	0.000138	0.00192	CcSEcCtD
Idarubicin—Anaemia—Azathioprine—multiple sclerosis	0.000138	0.00192	CcSEcCtD
Idarubicin—Leukopenia—Azathioprine—multiple sclerosis	0.000134	0.00186	CcSEcCtD
Idarubicin—Cardiac failure congestive—Prednisone—multiple sclerosis	0.000132	0.00183	CcSEcCtD
Idarubicin—Decreased appetite—Cladribine—multiple sclerosis	0.000131	0.00181	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000127	0.00176	CcSEcCtD
Idarubicin—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000125	0.00174	CcSEcCtD
Idarubicin—TOP2A—Methyltestosterone—Prednisone—multiple sclerosis	0.000125	0.0989	CbGdCrCtD
Idarubicin—Chills—Mitoxantrone—multiple sclerosis	0.000125	0.00173	CcSEcCtD
Idarubicin—Neoplasm—Methotrexate—multiple sclerosis	0.000125	0.00173	CcSEcCtD
Idarubicin—Myocardial infarction—Prednisolone—multiple sclerosis	0.000125	0.00173	CcSEcCtD
Idarubicin—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000124	0.00172	CcSEcCtD
Idarubicin—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000123	0.00171	CcSEcCtD
Idarubicin—Alopecia—Mitoxantrone—multiple sclerosis	0.000123	0.00171	CcSEcCtD
Idarubicin—TOP2A—Methyltestosterone—Prednisolone—multiple sclerosis	0.000122	0.0966	CbGdCrCtD
Idarubicin—Infection—Azathioprine—multiple sclerosis	0.000121	0.00169	CcSEcCtD
Idarubicin—Sepsis—Methotrexate—multiple sclerosis	0.00012	0.00166	CcSEcCtD
Idarubicin—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00012	0.00166	CcSEcCtD
Idarubicin—Urticaria—Cladribine—multiple sclerosis	0.000119	0.00166	CcSEcCtD
Idarubicin—Abdominal pain—Cladribine—multiple sclerosis	0.000119	0.00165	CcSEcCtD
Idarubicin—Body temperature increased—Cladribine—multiple sclerosis	0.000119	0.00165	CcSEcCtD
Idarubicin—Skin disorder—Azathioprine—multiple sclerosis	0.000119	0.00165	CcSEcCtD
Idarubicin—Thrombophlebitis—Methotrexate—multiple sclerosis	0.000116	0.00161	CcSEcCtD
Idarubicin—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000115	0.0016	CcSEcCtD
Idarubicin—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000115	0.0016	CcSEcCtD
Idarubicin—Haemoglobin—Prednisolone—multiple sclerosis	0.000115	0.00159	CcSEcCtD
Idarubicin—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000115	0.00159	CcSEcCtD
Idarubicin—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000114	0.00159	CcSEcCtD
Idarubicin—Haemorrhage—Prednisolone—multiple sclerosis	0.000114	0.00158	CcSEcCtD
Idarubicin—Anaemia—Mitoxantrone—multiple sclerosis	0.000112	0.00155	CcSEcCtD
Idarubicin—Hypersensitivity—Cladribine—multiple sclerosis	0.000111	0.00154	CcSEcCtD
Idarubicin—Leukopenia—Mitoxantrone—multiple sclerosis	0.000108	0.0015	CcSEcCtD
Idarubicin—Haemoglobin—Triamcinolone—multiple sclerosis	0.000105	0.00146	CcSEcCtD
Idarubicin—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000105	0.00146	CcSEcCtD
Idarubicin—Haemorrhage—Triamcinolone—multiple sclerosis	0.000105	0.00146	CcSEcCtD
Idarubicin—Convulsion—Mitoxantrone—multiple sclerosis	0.000105	0.00146	CcSEcCtD
Idarubicin—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000105	0.00145	CcSEcCtD
Idarubicin—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000105	0.00145	CcSEcCtD
Idarubicin—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000105	0.00145	CcSEcCtD
Idarubicin—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000104	0.00144	CcSEcCtD
Idarubicin—Myocardial infarction—Betamethasone—multiple sclerosis	0.000104	0.00144	CcSEcCtD
Idarubicin—Chest pain—Mitoxantrone—multiple sclerosis	0.000103	0.00143	CcSEcCtD
Idarubicin—Diarrhoea—Cladribine—multiple sclerosis	0.000103	0.00143	CcSEcCtD
Idarubicin—Arrhythmia—Prednisolone—multiple sclerosis	0.000102	0.00141	CcSEcCtD
Idarubicin—Gastrointestinal pain—Azathioprine—multiple sclerosis	9.99e-05	0.00139	CcSEcCtD
Idarubicin—Anaphylactic shock—Mitoxantrone—multiple sclerosis	9.88e-05	0.00137	CcSEcCtD
Idarubicin—Infection—Mitoxantrone—multiple sclerosis	9.82e-05	0.00136	CcSEcCtD
Idarubicin—Shock—Mitoxantrone—multiple sclerosis	9.72e-05	0.00135	CcSEcCtD
Idarubicin—Neutropenia—Prednisone—multiple sclerosis	9.69e-05	0.00134	CcSEcCtD
Idarubicin—Thrombocytopenia—Mitoxantrone—multiple sclerosis	9.67e-05	0.00134	CcSEcCtD
Idarubicin—Abdominal pain—Azathioprine—multiple sclerosis	9.66e-05	0.00134	CcSEcCtD
Idarubicin—Body temperature increased—Azathioprine—multiple sclerosis	9.66e-05	0.00134	CcSEcCtD
Idarubicin—Skin disorder—Mitoxantrone—multiple sclerosis	9.6e-05	0.00133	CcSEcCtD
Idarubicin—Haemoglobin—Dexamethasone—multiple sclerosis	9.57e-05	0.00133	CcSEcCtD
Idarubicin—Haemoglobin—Betamethasone—multiple sclerosis	9.57e-05	0.00133	CcSEcCtD
Idarubicin—Vomiting—Cladribine—multiple sclerosis	9.56e-05	0.00133	CcSEcCtD
Idarubicin—Haemorrhage—Betamethasone—multiple sclerosis	9.52e-05	0.00132	CcSEcCtD
Idarubicin—Haemorrhage—Dexamethasone—multiple sclerosis	9.52e-05	0.00132	CcSEcCtD
Idarubicin—Angiopathy—Methylprednisolone—multiple sclerosis	9.5e-05	0.00132	CcSEcCtD
Idarubicin—Rash—Cladribine—multiple sclerosis	9.48e-05	0.00132	CcSEcCtD
Idarubicin—Dermatitis—Cladribine—multiple sclerosis	9.47e-05	0.00131	CcSEcCtD
Idarubicin—Immune system disorder—Methylprednisolone—multiple sclerosis	9.46e-05	0.00131	CcSEcCtD
Idarubicin—Anorexia—Mitoxantrone—multiple sclerosis	9.42e-05	0.00131	CcSEcCtD
Idarubicin—Headache—Cladribine—multiple sclerosis	9.42e-05	0.00131	CcSEcCtD
Idarubicin—Arrhythmia—Triamcinolone—multiple sclerosis	9.37e-05	0.0013	CcSEcCtD
Idarubicin—Arrhythmia—Methylprednisolone—multiple sclerosis	9.35e-05	0.0013	CcSEcCtD
Idarubicin—Malnutrition—Methylprednisolone—multiple sclerosis	9.11e-05	0.00126	CcSEcCtD
Idarubicin—Acute coronary syndrome—Prednisone—multiple sclerosis	9.1e-05	0.00126	CcSEcCtD
Idarubicin—Myocardial infarction—Prednisone—multiple sclerosis	9.05e-05	0.00126	CcSEcCtD
Idarubicin—Hypersensitivity—Azathioprine—multiple sclerosis	9e-05	0.00125	CcSEcCtD
Idarubicin—Nausea—Cladribine—multiple sclerosis	8.93e-05	0.00124	CcSEcCtD
Idarubicin—Angiopathy—Dexamethasone—multiple sclerosis	8.64e-05	0.0012	CcSEcCtD
Idarubicin—Angiopathy—Betamethasone—multiple sclerosis	8.64e-05	0.0012	CcSEcCtD
Idarubicin—Convulsion—Prednisolone—multiple sclerosis	8.61e-05	0.00119	CcSEcCtD
Idarubicin—Decreased appetite—Mitoxantrone—multiple sclerosis	8.59e-05	0.00119	CcSEcCtD
Idarubicin—Arrhythmia—Dexamethasone—multiple sclerosis	8.5e-05	0.00118	CcSEcCtD
Idarubicin—Arrhythmia—Betamethasone—multiple sclerosis	8.5e-05	0.00118	CcSEcCtD
Idarubicin—Alopecia—Betamethasone—multiple sclerosis	8.41e-05	0.00117	CcSEcCtD
Idarubicin—Alopecia—Dexamethasone—multiple sclerosis	8.41e-05	0.00117	CcSEcCtD
Idarubicin—Diarrhoea—Azathioprine—multiple sclerosis	8.36e-05	0.00116	CcSEcCtD
Idarubicin—Haemoglobin—Prednisone—multiple sclerosis	8.33e-05	0.00116	CcSEcCtD
Idarubicin—Haemorrhage—Prednisone—multiple sclerosis	8.29e-05	0.00115	CcSEcCtD
Idarubicin—Pancytopenia—Methotrexate—multiple sclerosis	8.22e-05	0.00114	CcSEcCtD
Idarubicin—Anaphylactic shock—Prednisolone—multiple sclerosis	8.11e-05	0.00113	CcSEcCtD
Idarubicin—Neutropenia—Methotrexate—multiple sclerosis	8.09e-05	0.00112	CcSEcCtD
Idarubicin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	8.08e-05	0.00112	CcSEcCtD
Idarubicin—Shock—Prednisolone—multiple sclerosis	7.97e-05	0.00111	CcSEcCtD
Idarubicin—Convulsion—Triamcinolone—multiple sclerosis	7.91e-05	0.0011	CcSEcCtD
Idarubicin—Convulsion—Methylprednisolone—multiple sclerosis	7.9e-05	0.0011	CcSEcCtD
Idarubicin—Urticaria—Mitoxantrone—multiple sclerosis	7.85e-05	0.00109	CcSEcCtD
Idarubicin—Body temperature increased—Mitoxantrone—multiple sclerosis	7.81e-05	0.00108	CcSEcCtD
Idarubicin—Abdominal pain—Mitoxantrone—multiple sclerosis	7.81e-05	0.00108	CcSEcCtD
Idarubicin—Vomiting—Azathioprine—multiple sclerosis	7.77e-05	0.00108	CcSEcCtD
Idarubicin—Rash—Azathioprine—multiple sclerosis	7.71e-05	0.00107	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	7.71e-05	0.00107	CcSEcCtD
Idarubicin—Dermatitis—Azathioprine—multiple sclerosis	7.7e-05	0.00107	CcSEcCtD
Idarubicin—Flushing—Prednisone—multiple sclerosis	7.69e-05	0.00107	CcSEcCtD
Idarubicin—Headache—Azathioprine—multiple sclerosis	7.66e-05	0.00106	CcSEcCtD
Idarubicin—Stomatitis—Methotrexate—multiple sclerosis	7.52e-05	0.00104	CcSEcCtD
Idarubicin—Angiopathy—Prednisone—multiple sclerosis	7.52e-05	0.00104	CcSEcCtD
Idarubicin—Immune system disorder—Prednisone—multiple sclerosis	7.49e-05	0.00104	CcSEcCtD
Idarubicin—Anaphylactic shock—Triamcinolone—multiple sclerosis	7.45e-05	0.00103	CcSEcCtD
Idarubicin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	7.44e-05	0.00103	CcSEcCtD
Idarubicin—Arrhythmia—Prednisone—multiple sclerosis	7.41e-05	0.00103	CcSEcCtD
Idarubicin—Infection—Triamcinolone—multiple sclerosis	7.41e-05	0.00103	CcSEcCtD
Idarubicin—Infection—Methylprednisolone—multiple sclerosis	7.39e-05	0.00103	CcSEcCtD
Idarubicin—Shock—Triamcinolone—multiple sclerosis	7.33e-05	0.00102	CcSEcCtD
Idarubicin—Alopecia—Prednisone—multiple sclerosis	7.33e-05	0.00102	CcSEcCtD
Idarubicin—Shock—Methylprednisolone—multiple sclerosis	7.32e-05	0.00102	CcSEcCtD
Idarubicin—Hypersensitivity—Mitoxantrone—multiple sclerosis	7.28e-05	0.00101	CcSEcCtD
Idarubicin—Nausea—Azathioprine—multiple sclerosis	7.26e-05	0.00101	CcSEcCtD
Idarubicin—Skin disorder—Methylprednisolone—multiple sclerosis	7.22e-05	0.001	CcSEcCtD
Idarubicin—Malnutrition—Prednisone—multiple sclerosis	7.22e-05	0.001	CcSEcCtD
Idarubicin—Convulsion—Dexamethasone—multiple sclerosis	7.18e-05	0.000997	CcSEcCtD
Idarubicin—Convulsion—Betamethasone—multiple sclerosis	7.18e-05	0.000997	CcSEcCtD
Idarubicin—Haemoglobin—Methotrexate—multiple sclerosis	6.96e-05	0.000967	CcSEcCtD
Idarubicin—Haemorrhage—Methotrexate—multiple sclerosis	6.93e-05	0.000962	CcSEcCtD
Idarubicin—Urinary tract disorder—Methotrexate—multiple sclerosis	6.84e-05	0.00095	CcSEcCtD
Idarubicin—Urethral disorder—Methotrexate—multiple sclerosis	6.79e-05	0.000943	CcSEcCtD
Idarubicin—Anaphylactic shock—Dexamethasone—multiple sclerosis	6.76e-05	0.000939	CcSEcCtD
Idarubicin—Anaphylactic shock—Betamethasone—multiple sclerosis	6.76e-05	0.000939	CcSEcCtD
Idarubicin—Diarrhoea—Mitoxantrone—multiple sclerosis	6.76e-05	0.000938	CcSEcCtD
Idarubicin—Infection—Dexamethasone—multiple sclerosis	6.72e-05	0.000933	CcSEcCtD
Idarubicin—Infection—Betamethasone—multiple sclerosis	6.72e-05	0.000933	CcSEcCtD
Idarubicin—Anaemia—Prednisone—multiple sclerosis	6.67e-05	0.000926	CcSEcCtD
Idarubicin—Shock—Betamethasone—multiple sclerosis	6.65e-05	0.000924	CcSEcCtD
Idarubicin—Shock—Dexamethasone—multiple sclerosis	6.65e-05	0.000924	CcSEcCtD
Idarubicin—Thrombocytopenia—Betamethasone—multiple sclerosis	6.62e-05	0.000919	CcSEcCtD
Idarubicin—Thrombocytopenia—Dexamethasone—multiple sclerosis	6.62e-05	0.000919	CcSEcCtD
Idarubicin—Anorexia—Dexamethasone—multiple sclerosis	6.45e-05	0.000895	CcSEcCtD
Idarubicin—Anorexia—Betamethasone—multiple sclerosis	6.45e-05	0.000895	CcSEcCtD
Idarubicin—Urticaria—Prednisolone—multiple sclerosis	6.44e-05	0.000894	CcSEcCtD
Idarubicin—Angiopathy—Methotrexate—multiple sclerosis	6.29e-05	0.000873	CcSEcCtD
Idarubicin—Vomiting—Mitoxantrone—multiple sclerosis	6.28e-05	0.000872	CcSEcCtD
Idarubicin—Immune system disorder—Methotrexate—multiple sclerosis	6.26e-05	0.000869	CcSEcCtD
Idarubicin—Convulsion—Prednisone—multiple sclerosis	6.25e-05	0.000868	CcSEcCtD
Idarubicin—Rash—Mitoxantrone—multiple sclerosis	6.23e-05	0.000865	CcSEcCtD
Idarubicin—Dermatitis—Mitoxantrone—multiple sclerosis	6.22e-05	0.000864	CcSEcCtD
Idarubicin—Chills—Methotrexate—multiple sclerosis	6.22e-05	0.000863	CcSEcCtD
Idarubicin—Headache—Mitoxantrone—multiple sclerosis	6.19e-05	0.000859	CcSEcCtD
Idarubicin—Alopecia—Methotrexate—multiple sclerosis	6.12e-05	0.00085	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	6.1e-05	0.000847	CcSEcCtD
Idarubicin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.08e-05	0.000844	CcSEcCtD
Idarubicin—Malnutrition—Methotrexate—multiple sclerosis	6.03e-05	0.000837	CcSEcCtD
Idarubicin—Hypersensitivity—Prednisolone—multiple sclerosis	5.97e-05	0.000829	CcSEcCtD
Idarubicin—Urticaria—Triamcinolone—multiple sclerosis	5.92e-05	0.000822	CcSEcCtD
Idarubicin—Urticaria—Methylprednisolone—multiple sclerosis	5.91e-05	0.00082	CcSEcCtD
Idarubicin—Body temperature increased—Triamcinolone—multiple sclerosis	5.89e-05	0.000818	CcSEcCtD
Idarubicin—Anaphylactic shock—Prednisone—multiple sclerosis	5.89e-05	0.000818	CcSEcCtD
Idarubicin—Abdominal pain—Methylprednisolone—multiple sclerosis	5.88e-05	0.000816	CcSEcCtD
Idarubicin—Decreased appetite—Betamethasone—multiple sclerosis	5.88e-05	0.000816	CcSEcCtD
Idarubicin—Decreased appetite—Dexamethasone—multiple sclerosis	5.88e-05	0.000816	CcSEcCtD
Idarubicin—Nausea—Mitoxantrone—multiple sclerosis	5.87e-05	0.000815	CcSEcCtD
Idarubicin—Infection—Prednisone—multiple sclerosis	5.85e-05	0.000812	CcSEcCtD
Idarubicin—Shock—Prednisone—multiple sclerosis	5.79e-05	0.000804	CcSEcCtD
Idarubicin—Skin disorder—Prednisone—multiple sclerosis	5.72e-05	0.000794	CcSEcCtD
Idarubicin—Anorexia—Prednisone—multiple sclerosis	5.61e-05	0.000779	CcSEcCtD
Idarubicin—Anaemia—Methotrexate—multiple sclerosis	5.57e-05	0.000774	CcSEcCtD
Idarubicin—Gastrointestinal pain—Betamethasone—multiple sclerosis	5.53e-05	0.000768	CcSEcCtD
Idarubicin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	5.53e-05	0.000768	CcSEcCtD
Idarubicin—Hypersensitivity—Triamcinolone—multiple sclerosis	5.49e-05	0.000762	CcSEcCtD
Idarubicin—Hypersensitivity—Methylprednisolone—multiple sclerosis	5.48e-05	0.000761	CcSEcCtD
Idarubicin—Leukopenia—Methotrexate—multiple sclerosis	5.4e-05	0.000749	CcSEcCtD
Idarubicin—Urticaria—Betamethasone—multiple sclerosis	5.37e-05	0.000746	CcSEcCtD
Idarubicin—Urticaria—Dexamethasone—multiple sclerosis	5.37e-05	0.000746	CcSEcCtD
Idarubicin—Body temperature increased—Dexamethasone—multiple sclerosis	5.35e-05	0.000742	CcSEcCtD
Idarubicin—Body temperature increased—Betamethasone—multiple sclerosis	5.35e-05	0.000742	CcSEcCtD
Idarubicin—Abdominal pain—Dexamethasone—multiple sclerosis	5.35e-05	0.000742	CcSEcCtD
Idarubicin—Abdominal pain—Betamethasone—multiple sclerosis	5.35e-05	0.000742	CcSEcCtD
Idarubicin—Convulsion—Methotrexate—multiple sclerosis	5.23e-05	0.000725	CcSEcCtD
Idarubicin—Chest pain—Methotrexate—multiple sclerosis	5.13e-05	0.000713	CcSEcCtD
Idarubicin—Decreased appetite—Prednisone—multiple sclerosis	5.12e-05	0.000711	CcSEcCtD
Idarubicin—Rash—Prednisolone—multiple sclerosis	5.11e-05	0.000709	CcSEcCtD
Idarubicin—Dermatitis—Prednisolone—multiple sclerosis	5.11e-05	0.000709	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.1e-05	0.000708	CcSEcCtD
Idarubicin—Diarrhoea—Methylprednisolone—multiple sclerosis	5.09e-05	0.000706	CcSEcCtD
Idarubicin—Headache—Prednisolone—multiple sclerosis	5.08e-05	0.000705	CcSEcCtD
Idarubicin—Anaphylactic shock—Methotrexate—multiple sclerosis	4.92e-05	0.000683	CcSEcCtD
Idarubicin—Infection—Methotrexate—multiple sclerosis	4.89e-05	0.000679	CcSEcCtD
Idarubicin—Thrombocytopenia—Methotrexate—multiple sclerosis	4.82e-05	0.000669	CcSEcCtD
Idarubicin—Gastrointestinal pain—Prednisone—multiple sclerosis	4.82e-05	0.000669	CcSEcCtD
Idarubicin—Nausea—Prednisolone—multiple sclerosis	4.81e-05	0.000668	CcSEcCtD
Idarubicin—Skin disorder—Methotrexate—multiple sclerosis	4.78e-05	0.000664	CcSEcCtD
Idarubicin—Vomiting—Triamcinolone—multiple sclerosis	4.74e-05	0.000658	CcSEcCtD
Idarubicin—Vomiting—Methylprednisolone—multiple sclerosis	4.73e-05	0.000656	CcSEcCtD
Idarubicin—Rash—Triamcinolone—multiple sclerosis	4.7e-05	0.000652	CcSEcCtD
Idarubicin—Dermatitis—Triamcinolone—multiple sclerosis	4.7e-05	0.000652	CcSEcCtD
Idarubicin—Anorexia—Methotrexate—multiple sclerosis	4.69e-05	0.000651	CcSEcCtD
Idarubicin—Rash—Methylprednisolone—multiple sclerosis	4.69e-05	0.000651	CcSEcCtD
Idarubicin—Dermatitis—Methylprednisolone—multiple sclerosis	4.69e-05	0.00065	CcSEcCtD
Idarubicin—Urticaria—Prednisone—multiple sclerosis	4.68e-05	0.000649	CcSEcCtD
Idarubicin—Headache—Triamcinolone—multiple sclerosis	4.67e-05	0.000648	CcSEcCtD
Idarubicin—Headache—Methylprednisolone—multiple sclerosis	4.66e-05	0.000647	CcSEcCtD
Idarubicin—Abdominal pain—Prednisone—multiple sclerosis	4.66e-05	0.000646	CcSEcCtD
Idarubicin—Body temperature increased—Prednisone—multiple sclerosis	4.66e-05	0.000646	CcSEcCtD
Idarubicin—Diarrhoea—Dexamethasone—multiple sclerosis	4.63e-05	0.000642	CcSEcCtD
Idarubicin—Diarrhoea—Betamethasone—multiple sclerosis	4.63e-05	0.000642	CcSEcCtD
Idarubicin—Nausea—Triamcinolone—multiple sclerosis	4.43e-05	0.000615	CcSEcCtD
Idarubicin—Nausea—Methylprednisolone—multiple sclerosis	4.42e-05	0.000613	CcSEcCtD
Idarubicin—Hypersensitivity—Prednisone—multiple sclerosis	4.34e-05	0.000602	CcSEcCtD
Idarubicin—Vomiting—Betamethasone—multiple sclerosis	4.3e-05	0.000597	CcSEcCtD
Idarubicin—Vomiting—Dexamethasone—multiple sclerosis	4.3e-05	0.000597	CcSEcCtD
Idarubicin—Decreased appetite—Methotrexate—multiple sclerosis	4.28e-05	0.000594	CcSEcCtD
Idarubicin—Rash—Dexamethasone—multiple sclerosis	4.26e-05	0.000592	CcSEcCtD
Idarubicin—Rash—Betamethasone—multiple sclerosis	4.26e-05	0.000592	CcSEcCtD
Idarubicin—Dermatitis—Dexamethasone—multiple sclerosis	4.26e-05	0.000591	CcSEcCtD
Idarubicin—Dermatitis—Betamethasone—multiple sclerosis	4.26e-05	0.000591	CcSEcCtD
Idarubicin—Headache—Dexamethasone—multiple sclerosis	4.24e-05	0.000588	CcSEcCtD
Idarubicin—Headache—Betamethasone—multiple sclerosis	4.24e-05	0.000588	CcSEcCtD
Idarubicin—Diarrhoea—Prednisone—multiple sclerosis	4.03e-05	0.000559	CcSEcCtD
Idarubicin—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.03e-05	0.000559	CcSEcCtD
Idarubicin—Nausea—Betamethasone—multiple sclerosis	4.02e-05	0.000558	CcSEcCtD
Idarubicin—Nausea—Dexamethasone—multiple sclerosis	4.02e-05	0.000558	CcSEcCtD
Idarubicin—Urticaria—Methotrexate—multiple sclerosis	3.91e-05	0.000543	CcSEcCtD
Idarubicin—Abdominal pain—Methotrexate—multiple sclerosis	3.89e-05	0.00054	CcSEcCtD
Idarubicin—Body temperature increased—Methotrexate—multiple sclerosis	3.89e-05	0.00054	CcSEcCtD
Idarubicin—Vomiting—Prednisone—multiple sclerosis	3.75e-05	0.00052	CcSEcCtD
Idarubicin—Rash—Prednisone—multiple sclerosis	3.71e-05	0.000515	CcSEcCtD
Idarubicin—Dermatitis—Prednisone—multiple sclerosis	3.71e-05	0.000515	CcSEcCtD
Idarubicin—Headache—Prednisone—multiple sclerosis	3.69e-05	0.000512	CcSEcCtD
Idarubicin—Hypersensitivity—Methotrexate—multiple sclerosis	3.63e-05	0.000503	CcSEcCtD
Idarubicin—Nausea—Prednisone—multiple sclerosis	3.5e-05	0.000486	CcSEcCtD
Idarubicin—Diarrhoea—Methotrexate—multiple sclerosis	3.37e-05	0.000467	CcSEcCtD
Idarubicin—Vomiting—Methotrexate—multiple sclerosis	3.13e-05	0.000434	CcSEcCtD
Idarubicin—Rash—Methotrexate—multiple sclerosis	3.1e-05	0.000431	CcSEcCtD
Idarubicin—Dermatitis—Methotrexate—multiple sclerosis	3.1e-05	0.00043	CcSEcCtD
Idarubicin—Headache—Methotrexate—multiple sclerosis	3.08e-05	0.000428	CcSEcCtD
Idarubicin—Nausea—Methotrexate—multiple sclerosis	2.92e-05	0.000406	CcSEcCtD
